The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for advanced esophageal squamous cell carcinoma (ESCC): A multicenter, single-arm, open-label phase Ⅱ clinical trial.
 
Junsheng Wang
No Relationships to Disclose
 
Suxia Luo
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Tao Wu
No Relationships to Disclose
 
Yonggui Hong
No Relationships to Disclose
 
Yanzhen Guo
No Relationships to Disclose
 
Yufeng Cheng
No Relationships to Disclose
 
Baosheng Li
No Relationships to Disclose
 
Bingxu Tan
No Relationships to Disclose